Final Program

138 MONDAY • MAY 16
9:40 Empowering Patients with Asthma: Customizing Care to
Patient Beliefs
M.R. George, AE-C, PhD, RN, New York, NY
10:00 Why Wouldn’t I Want to Know? Moving Lung Cancer
Screening from Standardized to Personalized
R.S. Wiener, MD, MPH, Boston, MA
10:20 Great Expectations: Using Digital Tools to Assist ICU Patients,
Families, and Clinicians with Shared Decision Making
D.B. White, MD, MAS, Pittsburgh, PA
10:40 Transforming the Future of Effective Patient Provider
Communication Through Universal Decision Support
C.E. Cox, MD, MPH, Durham, NC
B7
There will be a 5-minute discussion after each talk.
CLINICAL
SCIENTIFIC SYMPOSIUM
CME Credits Available: 2.0
ONE STEP AT A TIME: HAS PHYSICAL ACTIVITY
DELIVERED AS AN OUTCOME IN CLINICAL
TRIALS?
Assemblies on Pulmonary Rehabilitation; Clinical Problems; Nursing
9:00 a.m. - 11:00 a.m. MOSCONE CENTER
Room 2020/2022 (West Building, Level 2)
Target Audience
Health care professionals who are interested in the measurement and
enhancement of clinical activity. Researchers who use physical activity as
outcomes in clinical trials.
Objectives
At the conclusion of this session, the participant will be able to:
• understand the importance of physical activity in patients with COPD and
the wider health implications of inactivity;
• learn about new developments with respect to measuring physical activity;
• understand new strategies to improve physical activity.
This session will provide an overview of the importance of physical activity to
the population at large and of course for those with respiratory disease,
specifically COPD. We will explore the development of the measurement, and
the physical and psychological benefits of physical activity. The complexities of
measurement for clinical trials will be addressed and finally how we might
improve physical activity through rehabilitation or novel technologies.
Chairing: S.J. Singh, PhD, Leicester, United Kingdom
M.L. Moy, MD, MSc, Boston, MA
9:00 The (Short) History of Physical Activity Measurement in COPD
R. Casaburi, MD, PhD, Torrance, CA
9:10 Physical Activity: Does it Keep Us Alive?
J. Myers, PhD, Palo Alto, CA
9:35 Physical Activity: Does it Keep Those with COPD Happy? The
Patient Centered Perspective
T. Troosters, PhD, Leuven, Belgium
10:00 Physical Activity: Should it Be an Outcome for Large Clinical
Trials?
A. Hamilton, PhD, Burlington, Canada
10:20 Enhancing Physical Activity with Rehabilitation
R.S. Goldstein, MD, Toronto, Canada
10:40 How Can We Use Technology to Improve Physical Activity for
Individuals with COPD?
H. Demeyer, PhD, Leuven, Belgium
This session and the International Conference are supported by an educational grant from
AstraZeneca LP.
All CME sessions have been planned and implemented in accordance with the Essential
Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME)
and are free of the control of commercial interests.
B8
CLINICAL
SCIENTIFIC SYMPOSIUM
CME Credits Available: 2.0
SLEEP, SLEEP DISORDERS AND PERFORMANCE
IN ATHLETES
Assemblies on Sleep and Respiratory Neurobiology, Behavioral Science
and Health Services Research
9:00 a.m. - 11:00 a.m. MOSCONE CENTER
Room 2001/2003 (West Building, Level 2)
Target Audience
Sleep physicians, those interested in public health, those interested in human
performance, those interested in real-world applications of sleep medicine
Objectives
At the conclusion of this session, the participant will be able to:
• learn new findings about the role of sleep and health in athletic performance;
• better understand how sleep impacts health and performance from the
perspective of an elite athlete;
• better assess, diagnose, and treat sleep disorders among athletes.
Insufficient and/or misaligned sleep, sleep apnea and other sleep disorders have
been shown to impact health, neurocognitive and physical performance. In addition,
training at altitudes, hypoxic training, and other respiratory effects have also been
studied. These are all domains that are relevant to athletes. For this reason, there
has been increased attention from both the scientific community and from athletic
organizations regarding the importance of sleep and respiratory health. Some of this
effort has focused on the high prevalence of sleep apnea in football players. Further,
the National Collegiate Athletic Association recently adopted best practices for
addressing mental health in student athletes, and screening for sleep disorders
(including sleep apnea) is prominently featured in those guidelines. This session will
be the first of its kind at the ATS meeting and will focus on the (1) state of the
science of sleep and respiratory health in athletes and then delve into the specific
areas of (2) the new NCAA guidelines for student athletes related to sleep and (3)
sleep apnea in athletes, football players specifically. Finally, the session will feature
the perspectives of a professional athlete and a coach who can discuss their
experiences when it comes to sleep and related aspects in maintaining performance.
Chairing:M. Grandner, PhD, Tucson, AZ
P.J. Strollo, MD, Pittsburgh, PA
S. Halson, PhD, Belconnen, Australia
ATS 2016 • San Francisco